Companies
/Healthcare
Fulgent Genetics Inc
$20.45
▲ $0.33 (+1.64%) today
Markets closed · 3:08am ET
Today · % change
Fundamentals
Market Cap
$553.6M
Profit Margin
-26.1%
Revenue (TTM)
$323.9M
EPS (TTM)
$-2.83
52-Week Range
$13 – $31
Street Target
$19.00
About Fulgent Genetics
Fulgent Genetics Inc is a dynamic company specializing in clinical diagnostic and genetic testing solutions. Based in El Monte, California, and founded in 2011, it offers a wide range of services including molecular diagnostic testing, genetic testing, various pathology laboratory tests, oncology tests, and sequencer services for hereditary cancer, reproductive health, and more. Fulgent Genetics also focuses on therapeutic development, particularly in enhancing cancer treatment through nanoencapsulation and targeted therapy platforms. Its innovative picture genetics platform aids in identifying personal health markers, serving a diverse clientele including insurance companies, hospitals, medical institutions, and individuals.